Lung Cancer Trials Ask AI to find trials
RecruitingNot applicableNCT06726590
Official study title

Interprofessional Pharmacogenomics (IPGx) Registry and Repository

Study summary

This program collects genetic and health information to help doctors choose the right medications for patients.

Ask AI to explain this study
Start here

Key things to know

Main goalNot specified

This describes the study’s primary purpose.

What is being studiedNot specified

The study team can explain what participation involves.

Who it may be forDiabetes · Cholesterol

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Sep 12, 2025 · Source: ClinicalTrials.gov

Is enrollment open?Recruiting

The study is currently accepting participants.

What kind of study?Not applicable

Observational

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?Texas A&M University

Study sponsor

01
Study overview

What this study is about

Purpose
Not specified
Study type
Observational
Phase
Not applicable
Sponsor
Texas A&M University
Interventions being studied
Not specified
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • The study will invite patients who are eligible for PGX workup/PGX care to participate, provided they meet the following criteria: Use of five or more medications, including over the counter drugs, supplements, natural products, cannabis products, or other recreational drugs, or
  • Individuals taking blood pressure or depression medications, even if less than five medications.
  • Ability to understand and give consent.
  • Able to consent to donate blood and/or urine samples and buccal swabs.
  • Able to answer detailed questionnaires, including quarterly questionnaires about ADRs, cognitive testing such as serial mini-mental status exams, and or quality of life questions.
  • Able to understand that their health record and changes in health status will be followed for a five-year period and shared in deidentified form with the research community.
  • All genders.
  • Any age over 18 years.
Reasons someone may not be able to joinExclusion criteria
  • Individuals admitted to hospice.
  • Declines to participate or interact with staff/share their medical status.
  • A diagnosis of Alzheimer's disease or related dementias in a medical record as this indicates a progressive, debilitating condition that impairs memory, thought processes, and functioning.,
  • Individuals who are unable or unwilling to provide consent.
  • Unable to verbally communicate and comprehend English language

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Texas A&M Family CareBryan, Texas

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Sep 12, 2025. Always confirm current availability with the study team.

View original record ↗